ATNM
AMEX · Biotechnology
Actinium Pharmaceuticals Inc
$1.04
+0.08 (+7.90%)
Open$0.95
Previous Close$0.96
Day High$1.09
Day Low$0.94
52W High$1.81
52W Low$0.74
Volume—
Avg Volume178.1K
Market Cap30.31M
P/E Ratio—
EPS$-0.75
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,372.1% upside
Current
$1.04
$1.04
Target
$36.11
$36.11
$23.47
$36.11 avg
$39.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 84.5K | 190.5K | 4.99M |
| Net Income | -31,655,617 | -64,210,176 | -1,193,914 |
| Profit Margin | -37,652.2% | -35,769.6% | -23.9% |
| EBITDA | -33,698,385 | -72,151,151 | -1,575,968 |
| Free Cash Flow | — | — | -691,464 |
| Rev Growth | -55.6% | -55.6% | +20.9% |
| Debt/Equity | 0.00 | 0.00 | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |